Twitter icon Email alerts icon Latest News RSS icon Magazine icon Stay connected:

View the article online at http://citywire.co.uk/wealth-manager/article/a639698

Garrett-Cox takes aim at Alliance Trust critics

by Rachael Revesz on Dec 04, 2012 at 13:14

Di Bon has also added Roche, the Swiss pharmaceuticals company, as a pioneer in personalised medicine, as well as Qualcomm, a US mobile technology company, which is now the second largest holding in the trust.

‘Once we identify our best ideas we make sure that, over time, they can have a very meaningful impact instead of being diluted across a number of lower conviction holdings,’ he said.

Sign in / register to view full article on one page

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

Long time coming: is the recovery here to stay?


Ian McVeigh and Steve Davies, managers of Jupiter's UK Growth fund, talk about their predictions for the UK equity space. Click here to watch a series of sponsored interviews with Jupiter's fund managers on the UK equity market.

Today's top headlines

The Citywire guide to investment trusts

Investment trusts have proved to be a highly effective way to invest in the market. Citywire has interviewed the experts to find out more.

More about this:

Look up the shares

  • Alliance Trust PLC
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Look up the fund managers

  • Katherine Garrett-Cox
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

More from us

Archive

On the road

Click here to find out more from the Audience Development team.

Read more...

Co-op files £2.5bn loss after 'disastrous' 2013

by David Campbell on Apr 17, 2014 at 09:20

Sorry, this link is not
quite ready yet